{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:24:55Z","timestamp":1765887895392},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ejphar.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T06:15:44Z","timestamp":1493705744000},"page":"71-74","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Effects of chronic bryostatin-1 on treatment-resistant depression in rats"],"prefix":"10.1016","volume":"807","author":[{"given":"Daniel L.","family":"Alkon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarin","family":"Hongpaisan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao-Kun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2017.05.001_bib1","doi-asserted-by":"crossref","first-page":"16432","DOI":"10.1073\/pnas.0508001102","article-title":"Protein synthesis required for long-term memory is induced by PKC activation on days before associative learning","volume":"102","author":"Alkon","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2017.05.001_bib2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/npp.2013.342","article-title":"Innovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects?","volume":"39","author":"Belzung","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2017.05.001_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/(SICI)1520-6394(1997)5:4<154::AID-DA2>3.0.CO;2-D","article-title":"Treatment-refractory depression: definitions and characteristics","volume":"5","author":"Berman","year":"1997","journal-title":"Depression Anxiety"},{"key":"10.1016\/j.ejphar.2017.05.001_bib4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/da.22505","article-title":"Ketamine for treatment-resistant unipolar and bipolar major depression: critical review and implications for clinical practice","volume":"33","author":"Bobo","year":"2016","journal-title":"Depression Anxiety"},{"key":"10.1016\/j.ejphar.2017.05.001_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2017.05.001_bib6","first-page":"51","article-title":"Swimming in small laboratory animals","volume":"2","author":"Dawson","year":"1970","journal-title":"Med. Sci. Sports"},{"key":"10.1016\/j.ejphar.2017.05.001_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/da.10102","article-title":"Selective memory and memory deficits in depressed inpatients","volume":"17","author":"Ellwart","year":"2003","journal-title":"Depression Anxiety"},{"key":"10.1016\/j.ejphar.2017.05.001_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.05.001_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2015.17.2\/dionescu","article-title":"Pharmacological approaches to the challenge of treatment-resistant depression","volume":"17","author":"Ionescu","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2017.05.001_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-publhealth-031912-114409","article-title":"The epidemiology of depression across cultures","volume":"34","author":"Kessler","year":"2013","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.ejphar.2017.05.001_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jad.2016.05.077","article-title":"A pilot study of hippocampal N-acetyl-aspartate in youth with treatment resistant major depression","volume":"207","author":"Lefebvre","year":"2017","journal-title":"J. Affect. Dis."},{"key":"10.1016\/j.ejphar.2017.05.001_bib12","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejphar.2017.05.001_bib13","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/sj.npp.1301652","article-title":"Novel drugs and therapeutic tar-gets for severe mood disorders","volume":"33","author":"Mathew","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2017.05.001_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2017.05.001_bib15","first-page":"327","article-title":"Behavioural despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1997","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2017.05.001_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0165-0270(03)00068-2","article-title":"Open space swimming test to index antidepressant activity","volume":"126","author":"Sun","year":"2003","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2017.05.001_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuroscience.2004.07.041","article-title":"Induced depressive behavior impairs learning and memory in rats","volume":"129","author":"Sun","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2017.05.001_bib18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/FBP.0b013e328308f239","article-title":"Effects of age on susceptibility to the induction of depressive behavior and imipramine in rats","volume":"19","author":"Sun","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.05.001_bib19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/FBP.0b013e3283618afe","article-title":"Cerebral ischemia-induced difference in sensitivity to depression and potential therapeutics in rats","volume":"24","author":"Sun","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.05.001_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tips.2015.04.004","article-title":"Towards universal therapeutics for memory disorders","volume":"36","author":"Sun","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2017.05.001_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of out-comes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.05.001_bib22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/jamapsychiatry.2015.0987","article-title":"Suicide attempts in the US Army during the Wars in Afghanistan and Iraq, 2004 to 2009","volume":"72","author":"Ursano","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ejphar.2017.05.001_bib23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jad.2016.09.008","article-title":"Continuation phase intravenous ketamine in adults with treatment-resistant depression","volume":"206","author":"Vande Voort","year":"2016","journal-title":"J. Affect. Dis."},{"key":"10.1016\/j.ejphar.2017.05.001_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.13m08852","article-title":"Ketamine safety and tolerability in clinical trials for treatment-resistant depression","volume":"76","author":"Wan","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.05.001_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12264-014-1484-6","article-title":"Rapid-onset antidepressant efficacy of glutamatergic system modulators: the neural plasticity hypothesis of depression","volume":"31","author":"Wang","year":"2015","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ejphar.2017.05.001_bib26","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1007\/s00213-015-4034-7","article-title":"Treatment-resistant depression: are animal models of depression fit for purpose?","volume":"232","author":"Willner","year":"2015","journal-title":"Psychopharmacology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917303047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917303047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T03:11:25Z","timestamp":1658977885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917303047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":26,"alternative-id":["S0014299917303047"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.001","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of chronic bryostatin-1 on treatment-resistant depression in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}